Table 2 Implant level recordings at baseline, and at 6 months and 12 months and change (Δ) from baseline and 6 months for clinical parameters

Mean PD

 Test

4.5 ± 0.10

4.1 ± 0.10

4.2 ± 0.11

-0.4 ± 0.12

0.006

0.1 ± 0.10

0.415

-0.3 ± 0.13

0.107

 Control

4.4 ± 0.10

3.9 ± 0.09

3.8 ± 0.09

-0.5 ± 0.09

< 0.001

-0.1 ± 0.08

0.702

-0.6 ± 0.07

< 0.001

 Difference

0.1 ± 0.22

0.704

0.2 ± 0.24

0.410

0.4 ± 0.27

0.138

0.1 ± 0.14

0.428

0.2 ± 0.13

0.116

0.3 ± 0.14

0.029

Mean CBL

 Test

3.6 ± 0.22

3.3 ± 0.18

3.5 ± 0.21

-0.3 ± 0.28

0.611

-0.1 ± 0.08

0.328

-0.2 ± 0.30

0.881

 Control

3.1 ± 0.20

3.0 ± 0.23

3.4 ± 0.27

-0.1 ± 0.21

0.861

0.4 ± 0.21

0.186

0.3 ± 0.16

0.259

 Difference

0.5 ± 0.46

0.320

0.3 ± 0.43

0.488

-0.0 ± 0.52

0.960

-0.2 ± 0.35

0.648

-0.3 ± 0.22

0.222

-0.4 ± 0.34

0.210

PCF

 Test

89.5 ± 5.8

46.5 ± 5.2

51.1 ± 5.8

-43.0 ± 4.6

 < 0.001

4.6 ± 4.7

0.627

-38.3 ± 6.7

< 0.001

 Control

76.3 ± 5.9

49.7 ± 6.0

55.7 ± 5.9

-26.6 ± 6.4

0.002

6.0 ± 4.7

0.463

-20.6 ± 4.9

0.002

 Difference

13.1 ± 8.6

0.134

-3.2 ± 9.2

0.727

-4.6 ± 10.1

0.650

-16.4 ± 7.8

0.042

-1.4 ± 6.6

0.835

-17.8 ± 8.2

0.037

OR_0-6

OR_6-12

OR_0-12

Plaque (%)

 Test

45.2

19.2

34.6

0.29

0.125

2.22

0.535

0.64

0.753

 Control

54.8

38.7

45.2

0.52

0.554

1.30

0.927

0.68

0.763

 Odds ratio (OR)

0.68

0.508

0.38

0.188

0.64

0.479

0.56

0.487

1.71

0.584

0.95

0.945

BoP (%)

 Test

59.7

37.8

36.5

0.41

< 0.001

0.95

0.947

0.39

< 0.001

 Control

58.1

32.3

32.3

0.34

< 0.001

1.00

0.999

0.34

< 0.001

 Odds ratio (OR)

1.07

0.807

1.28

0.455

1.20

0.480

1.19

0.522

0.95

0.825

1.13

0.637

SUP (%)

 Test

32.3

7.7

7.7

0.18

0.019

1.00

0.999

0.18

0.019

 Control

16.7

6.5

6.5

0.34

0.210

1.00

0.999

0.34

0.210

 Odds ratio (OR)

2.38

0.218

1.21

0.858

1.21

0.858

0.51

0.427

1.00

0.999

0.51

0.427